Clinical-Stage Biopharma w/ a Novel Target Therapy - Business for Sale
Request Information
The contact information for this deal is locked. If you wish to unlock this information, you need to upgrade to SMB Deal Hunter Pro.
💊
Clinical-Stage Biopharma Targeting Brain Tumors in Texas
TX, US
Added 2 years ago
Biopharmaceuticals and Targeted Therapy Development
Development-stage biopharmaceutical company in Texas focused on a patented, orally available small-molecule therapy targeting brain tumors, with pre-clinical efficacy and regulatory designations in place.
Key Information
Asking
–
Revenue
–
Earnings
–
Multiple
–
Key Highlights
- Clinical-stage biopharmaceutical company focused on a novel, patented small-molecule therapy for brain cancers
- Therapeutic agent selectively targets and inhibits a transcription factor highly expressed in glioblastomas and other brain tumors
- Pre-clinical evidence demonstrates efficacy in tumor cell-based and animal models, including non-human primates
- Drug is orally available and achieves therapeutically relevant concentrations in brain tissue
- Favorable pre-clinical safety profile at relevant clinical doses
- Intellectual property includes issued patents in the US and all major markets
- Open US IND with orphan drug, fast track, and rare pediatric disease designations; Phase 1 clinical trials planned for H2 2024
Contact Info
Unlock Premium Features
Get everything you need to find, finance, and acquire your business
Personalized Deal Flow
On and off market deals curated to your search criteria.
Unlimited 1:1 M&A Support
Expert advisors to help you spot red flags, negotiate your offer, and hand hold you all the way to close.
Pre-Vetted Deal Team
- * Intros to our preferred lenders
- * Access to our investor community
- * Discounted 3rd party Financial and Legal diligence